Why some CEOs are ditching 5-year plans while others are making 10-year bets
Christine Tan speaks with Roger Lee of TAL Apparel, Michael Mertin of AT&S and Dr Prem Kumar Nair of IHH Healthcare about how CEOs are navigating constant disruption, from tariffs and supply chain shocks to AI and geopolitical risk. While Lee says TAL …
Americans are leaving the U.S. in record numbers and spending hundreds to learn how to do it
Expatsi’s “Move Abroad Con” attracted hundreds of Americans hoping to move overseas.
UAE and Saudi Arabia report drone incidents as Iran war deadlock drags on
A drone strike caused a fire at a nuclear power plant in the United Arab Emirates, officials said Sunday, while Saudi Arabia reported intercepting three drones.
G7 finance ministers to meet amid warning of economic consequences of prolonged Strait of Hormuz closure
G7 finance ministers are due to meet in Paris on Monday and Tuesday as long-term borrowing costs surge.
South Korea says it will pursue all options to avoid Samsung strike
The world’s largest memory chip maker and its South Korean labor union will resume pay talks on Monday with a government mediator.
‘Space has never been hotter’: Analysts reveal top stock picks as investors target intergalactic gains
The space sector is back in the spotlight for investors in a new era of intergalactic exploration.
CEOs are using AI to transform hospitals, factories and chipmaking
Christine Tan speaks with Dr Prem Kumar Nair of IHH Group, Roger Lee of TAL Apparel and Michael Mertin of AT&S about how artificial intelligence is reshaping healthcare, manufacturing and semiconductor production. The executives discuss how AI is impro…
Global oil stockpiles could hit record lows if Strait of Hormuz remains closed
The world’s oil stockpiles could approach all-time lows by the end of May due to the Strait of Hormuz closure, according to UBS.
UAE says its decision to leave OPEC was a strategic economic move, not a political one
The United Arab Emirates, which joined OPEC in 1967, announced last month it was leaving the oil producer group on May 1.
Why J&J thinks its new psoriasis pill could be one of its biggest drugs ever
Investors are counting drugs like Icotyde to accelerate J&J’s revenue growth rate.
